AIG
AXSM icon

American International Group’s Axsome Therapeutics AXSM Stock Holding History

American International Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,570
Closed -$1.4M – 279
2024
Q1 		$1.4M Sell
17,570
-151
-0.9% -$12.7K 0.01% 1139
2023
Q4 		$1.41M Buy
17,721
+162
+0.9% +$10.8K 0.01% 1140
2023
Q3 		$1.23M Buy
17,559
+1,724
+11% +$129K 0.01% 1140
2023
Q2 		$1.14M Buy
15,835
+368
+2% +$27.1K 0.01% 1177
2023
Q1 		$954K Buy
15,467
+307
+2% +$20.2K 0.01% 1237
2022
Q4 		$1.17M Buy
15,160
+1,040
+7% +$62.2K 0.01% 1146
2022
Q3 		$630K Buy
14,120
+679
+5% +$33.9K ﹤0.01% 1435
2022
Q2 		$515K Sell
13,441
-354
-3% -$11.2K ﹤0.01% 1586
2022
Q1 		$571K Sell
13,795
-971
-7% -$30.1K ﹤0.01% 1650
2021
Q4 		$558K Sell
14,766
-441
-3% -$16.2K ﹤0.01% 1745
2021
Q3 		$501K Sell
15,207
-362
-2% -$14.1K ﹤0.01% 1854
2021
Q2 		$1.05M Sell
15,569
-579
-4% -$34.7K ﹤0.01% 1486
2021
Q1 		$914K Buy
16,148
+43
+0.3% +$3.02K ﹤0.01% 1508
2020
Q4 		$1.31M Sell
16,105
-462
-3% -$34.5K ﹤0.01% 1267
2020
Q3 		$1.18M Sell
16,567
-378
-2% -$29.5K 0.01% 1167
2020
Q2 		$1.39M Buy
16,945
+960
+6% +$73.9K 0.01% 1081
2020
Q1 		$940K Buy
15,985
+227
+1% +$18.5K 0.01% 1137
2019
Q4 		$1.63M Sell
15,758
-132
-0.8% -$5.33K 0.01% 1091
2019
Q3 		$322K Buy
15,890
+406
+3% +$10.4K ﹤0.01% 1900
2019
Q2 		$399K Buy
+15,484
New +$310K ﹤0.01% 1825
2017
Q2 		– Sell
-6,840
Closed -$27K – 3082
2017
Q1 		$27K Buy
6,840
+448
+7% +$2.14K ﹤0.01% 2934
2016
Q4 		$43K Sell
6,392
-17
-0.3% -$119 ﹤0.01% 2885
2016
Q3 		$50.5K Buy
6,409
+9
+0.1% +$68 ﹤0.01% 2893
2016
Q2 		$48.3K Buy
+6,400
New +$59K ﹤0.01% 2961

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American International Group's AXSM Position: Q2 2024 in Review

American International Group sold out of Axsome Therapeutics (AXSM) in Q2 2024, closing a stake of 17,570 shares — an estimated $1.4M sold.

American International Group first reported a position in AXSM in Q2 2016 and held it in 24 quarters. The position peaked at $1.63M in Q4 2019. 256 funds tracked by Wall St. Rank hold AXSM as of Q2 2024.

  • American International Group reported no remaining Axsome Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 17,570 Axsome Therapeutics shares in Q2 2024, an estimated $1.4M.
  • American International Group first reported a position in Axsome Therapeutics in Q2 2016 and held it in 24 quarters.
  • American International Group's Axsome Therapeutics position peaked at $1.63M in Q4 2019.
  • 256 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.